These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 36897102)
1. Expression of micro-ribonucleic acids in thyroid nodules and serum to discriminate between follicular adenoma and cancer in patients with a fine needle aspiration biopsy classified as suspicious for follicular neoplasm: A preliminary study. Świrta JS; Wątor G; Seweryn M; Kapusta P; Barczyński M; Wołkow P Adv Clin Exp Med; 2023 Sep; 32(9):997-1007. PubMed ID: 36897102 [TBL] [Abstract][Full Text] [Related]
2. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy. Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Chen YT; Kitabayashi N; Zhou XK; Fahey TJ; Scognamiglio T Mod Pathol; 2008 Sep; 21(9):1139-46. PubMed ID: 18587330 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples. Mahmoudian-Sani MR; Amrollahi-Sharifabadi M; Taheri A; Hosseini SM; Tahmasebi K; Mobini GR Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167927 [TBL] [Abstract][Full Text] [Related]
5. [Risk factors of malignancy in patients with fine needle aspiration biopsy results interpreted as "suspicious for follicular neoplasm"]. Świrta J; Romaniszyn M; Barczyński M Wiad Lek; 2020; 73(7):1323-1329. PubMed ID: 32759413 [TBL] [Abstract][Full Text] [Related]
6. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity. Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101 [TBL] [Abstract][Full Text] [Related]
7. The diagnostic and prognostic role of miR-146b-5p in differentiated thyroid carcinomas. Ferraz C; Cunha GB; de Oliveira MMB; Tenório LR; Cury AN; Padovani RDP; Ward LS Front Endocrinol (Lausanne); 2024; 15():1390743. PubMed ID: 39036050 [TBL] [Abstract][Full Text] [Related]
8. miRNA expression profiling of 'noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas. Borrelli N; Denaro M; Ugolini C; Poma AM; Miccoli M; Vitti P; Miccoli P; Basolo F Mod Pathol; 2017 Jan; 30(1):39-51. PubMed ID: 27586203 [TBL] [Abstract][Full Text] [Related]
9. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features. Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. Kitano M; Rahbari R; Patterson EE; Steinberg SM; Prasad NB; Wang Y; Zeiger MA; Kebebew E Thyroid; 2012 Mar; 22(3):285-91. PubMed ID: 22304369 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues. Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771 [TBL] [Abstract][Full Text] [Related]
13. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears. Fassina A; Cappellesso R; Simonato F; Siri M; Ventura L; Tosato F; Busund LT; Pelizzo MR; Fassan M Cancer Cytopathol; 2014 Apr; 122(4):274-81. PubMed ID: 24327568 [TBL] [Abstract][Full Text] [Related]
14. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Eszlinger M; Paschke R Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161 [TBL] [Abstract][Full Text] [Related]
15. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma. Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595 [TBL] [Abstract][Full Text] [Related]
16. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy. Ha EJ; Baek JH; Lee JH; Song DE; Kim JK; Shong YK; Hong SJ Thyroid; 2013 Jun; 23(6):703-8. PubMed ID: 23544697 [TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules. Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935 [TBL] [Abstract][Full Text] [Related]
18. Suspicious for follicular neoplasm or follicular neoplasm? The dilemma of a pathologist and a surgeon. Stanek-Widera A; Biskup-Frużyńska M; Zembala-Nożyńska E; Półtorak S; Śnietura M; Lange D Endokrynol Pol; 2016; 67(1):17-22. PubMed ID: 26884111 [TBL] [Abstract][Full Text] [Related]
19. Application of biomarkers in the diagnosis of uncertain samples of core needle biopsy of thyroid nodules. Xiong Y; Li X; Liang L; Li D; Yan L; Li X; Di J; Li T Virchows Arch; 2021 Nov; 479(5):961-974. PubMed ID: 34308507 [TBL] [Abstract][Full Text] [Related]